MK-677 before and after results in human trials were real but modest: over 12 months, older adults on 25 mg/day gained about 1.1 kg of fat-free mass and 2.7 kg of body weight, with no gain in strength and no loss of body fat. Big online transformations almost always combine MK-677 with SARMs, hard training and a calorie surplus, and part of the scale change is water.

1.1 kg

of fat-free mass over 12 months on 25 mg/day

2.7 kg

of body weight, with no gain in strength

Below: what the trials measured week by week, what results look like in women, why photos can mislead, and the seven reader results from the original version of this article, with their photos. For the compound itself, see our MK-677 (ibutamoren) review.

MK-677 summary

MK-677 (ibutamoren) is an oral drug that copies the hunger hormone ghrelin. It makes the pituitary release more growth hormone, which raises IGF-1 (FDA 2024). It is not a SARM, it has never been approved as a medicine, and WADA bans it in sport (WADA 2026). Its best-documented effects are more IGF-1, more appetite, some extra lean mass and body weight, and higher blood sugar.

MK-677 before and after: what the studies measured

Study Who How long Before → after (vs placebo)
Nass 2008 65 healthy adults aged 60–81, 25 mg/day 12 months Fat-free mass +1.1 kg (placebo −0.5 kg); weight +2.7 kg (placebo +0.8 kg); limb fat +1.1 kg (placebo +0.24 kg); belly and total fat unchanged; strength and function unchanged
Svensson 1998 24 obese men aged 18–50, 25 mg/day 8 weeks IGF-1 about +40%; fat-free mass up; total and belly fat unchanged; metabolic rate up at 2 weeks only
Murphy 1998 8 adults dieting on 18 kcal/kg/day, 25 mg/day 7 days Nitrogen balance +0.31 g/day vs −1.48 g/day on placebo (protein spared during the diet)
Murphy 2001 292 women aged 64–85, 25 mg/day 12–18 months IGF-1 +39–45%; weight gain and swelling were common side effects
Bach 2004 161 adults 65+ after hip fracture 6 months IGF-1 +84% (placebo +17%); physical function not significantly better

Evidence

None of these trials included young people who lift weights, and none combined MK-677 with resistance training. So the numbers above are the floor of what was measured, not a prediction for a 25-year-old in the gym. They are also the only controlled numbers there are.

MK-677 results timeline: week by week

When What changed in studies
Week 1 GH up from the first dose; IGF-1 already higher after 7 days (Copinschi 1996); more deep and REM sleep in a 7-day sleep study (Copinschi 1997)
Weeks 2–4 IGF-1 141 → 219 µg/L at 2 weeks and 265 µg/L at 4 weeks; fasting glucose up (Chapman 1996)
Week 8 Fat-free mass measurably higher in obese men; fat unchanged (Svensson 1998)
First months More appetite, mild leg swelling and muscle pain, often easing within a few months (Nass 2008)
Month 12 Fat-free mass +1.1 kg, weight +2.7 kg, no strength change (Nass 2008)
After stopping IGF-1 back to baseline within about a month (Nass 2008)

MK-677 before and after 8 weeks: the closest controlled data is the 8-week trial in obese men, where fat-free mass rose but body fat did not change (Svensson 1998). If an 8-week photo shows a big drop in body fat, something other than MK-677 did most of the work.

MK-677 before and after in women

Women took part in several trials. The largest:

What the study found: Murphy 2001

Population
292 women aged 64 to 85 with low bone density
Dose
25 mg/day
Duration
up to 18 months
Result
IGF-1 rose 39–45%, and weight gain and swelling were among the most common side effects. A few women stopped because of high prolactin or raised liver enzymes (FDA 2024)

The 12-month trial and the first dose-finding trial also included women (Nass 2008, Chapman 1996). No trial studied young women who train. Result #7 below is a woman’s report.

Why MK-677 before and after photos can mislead

  • Water and weight: MK-677 adds body weight and causes mild swelling in many users (Nass 2008). A fuller look is partly fluid.
  • Other compounds: four of the seven reader results below combined MK-677 with SARMs such as ligandrol, RAD-140, YK-11 or S-23, which act on muscle directly.
  • What was really in the bottle: of 44 products sold online as SARMs, only 41% matched their label and 25% contained unlisted substances (Van Wagoner 2017). One man’s “MK-677” supplements also contained testosterone, estradiol and GH (Chong 2024).
  • Lighting, pump and posture: after photos are often taken in better light, after a workout and with better posture.
  • Training and food: the more someone eats and trains during a cycle, the less of the change belongs to the drug.

For other compounds, see SARMs before and after results, LGD-4033 + MK-677 results and RAD-140 before and after.

MK-677 Results With Before And After Pics

Editor’s note: these seven reports and photos come from the original version of this article. They are unverified individual reports: their provenance was not checked, the cycles are what each person said they took, and none of them is a measured result or a recommendation. Photos can’t separate muscle from water and fat, and lighting, pump, posture, training, diet and other compounds all change them. Four of the seven combined MK-677 with a SARM, so those changes can’t be credited to MK-677 alone. For what controlled trials measured, see the study table above.

MK-677 Results #1

MK-677 results #1: reader photos at day 1, week 6 and week 12

The person reported taking MK-677 on its own and showed photos at day 1, week 6 and week 12. The photos suggest a fuller upper body, but they can’t show how much of the change was muscle, water or fat. In the 12-month trial in older adults, fat-free mass rose about 1.1 kg (Nass 2008).

Reported use: MK-677 alone for 12 weeks, as the person described it; not a recommendation. Not verified.

MK-677 Results #2 (+ Ligandrol)

MK-677 and ligandrol results #2: reader before and after photos

This reader combined MK-677 with ligandrol (LGD-4033), a SARM that acts on muscle directly, so the change in the photos can’t be credited to MK-677. Part of the extra size on MK-677 is fluid: mild swelling was common in trials (Nass 2008).

Reported use: ligandrol with MK-677 for 8 weeks, then MK-677 alone for 4 weeks, as the person described it; not a recommendation. Not verified. The original text called the last four weeks “MK-677 as a PCT”; no trial has tested MK-677 for that (see MK-677 as PCT).

MK-677 Results #3 (+RAD 140)

MK-677 and RAD-140 results #3: reader before and after photos

This reader combined MK-677 with RAD-140, another SARM, over eight weeks. The original text credited most of the change to RAD-140. Visible vascularity and abdominal definition depend on body fat, water and lighting, and in trials MK-677 did not lower body fat (Svensson 1998).

Reported use: RAD-140 with MK-677 for 8 weeks, then MK-677 alone for 4 weeks, as the person described it; not a recommendation. Not verified.

MK-677 Results #4

The original version described a 12-week MK-677-only result, but this report has no photo left on the page, so there is nothing a reader can check. It is listed here only to keep the original set of seven complete.

Reported use: MK-677 alone for 12 weeks, as the person described it; not a recommendation. Not verified.

MK-677 Results #5 (+ YK11)

MK-677 and YK-11 results #5: reader before and after photos

This reader combined MK-677 with YK-11, a compound sold as a SARM with no published human trials (see the YK-11 review), and then took clomiphene. The original author described him as a “hardgainer”, and the change shown can’t be attributed to either compound from photos alone.

Reported use: YK-11 with MK-677 for 8 weeks, then clomiphene, as the person described it; not a recommendation. Not verified.

MK-677 Results #6 (+ S23)

MK-677 and S-23 results #6: reader before and after photos

This reader combined MK-677 with S-23, a SARM (see the S-23 review), and then took clomiphene. The photos show a larger frame in the after picture; how much of that is muscle, water or fat, and how much came from each compound, can’t be judged from photos.

Reported use: S-23 with MK-677 for 8 weeks, then clomiphene, as the person described it; not a recommendation. Not verified.

MK-677 Results #7

MK-677 results #7: a woman's before and after photos

A woman who reported taking MK-677 mainly to gain weight. Weight gain is one of the most consistent findings in trials, including in women, where weight gain and swelling were common side effects (Murphy 2001). No trial studied young women who train.

Reported use: MK-677 alone for 8 weeks, as the person described it; not a recommendation. Not verified.

My MK-677 Results

Editor’s note: this section summarizes the original author’s personal account from the earlier version of this page. It is one person’s unverified experience, not a measured result or a recommendation.

The original author described using MK-677 on and off for several years, including one 12-week run that is written up in the MK-677 log. The account is set against what trials measured below.

Muscle Mass

The author reported gaining about 5 pounds of muscle over 12 weeks, judged without a body-composition scan. For comparison, older adults gained about 1.1 kg of fat-free mass over 12 months in the largest trial, and fat-free mass includes water (Nass 2008).

Weight Gain

The author reported strong hunger and about 10 pounds of weight gain, some of it water. More appetite, weight gain and mild swelling are among the best-documented effects of MK-677 (Nass 2008), and blood sugar rose in trials as well (Chapman 1996).

Recovery Times

The author reported less soreness after workouts. No trial has measured recovery from training on MK-677; muscle pain was reported as a side effect in older adults (Nass 2008).

Memory And Learning

The author reported a possible improvement in memory and said it might have been a placebo effect. Memory and learning were not outcomes in the trials listed above.

Secondary Benefits

The author reported deeper sleep with vivid dreams, and changes in skin and hair. A 7-day sleep study found more deep and REM sleep (Copinschi 1997); skin and hair were not measured in trials. The original text also said MK-677 needs no PCT and can replace one; no trial has tested either claim (see MK-677 as PCT).

How to judge MK-677 results honestly

Whether you are reading other people’s results or looking at your own, these are the checks that separate a real change from noise:

  • Measure, don’t just photograph. Same scale, same time of day, same light and pose. Waist and limb measurements show water and fat changes that photos hide.
  • Expect the scale to rise. Weight went up about 2 kg more than on placebo over a year in the trials, and the “fat-free mass” those trials measured includes water as well as muscle (Nass 2008).
  • Know what the trials watched. Fasting glucose, HbA1c, liver enzymes, prolactin and blood pressure were where problems appeared, and trial doctors lowered doses or stopped treatment when they did (FDA 2024). See MK-677 side effects.
  • Check what you are taking. A batch-specific certificate of analysis from an independent lab is the minimum; our SwissChems review explains why it is our current partner shop.
  • Remember the timing. Most gains in the trials came over months, and IGF-1 fell back within a month of stopping (Nass 2008).

Doses studied, timing and trial lengths are on our MK-677 dosage and morning or night pages, and a week-by-week personal account is in the 12-week MK-677 log.

Conclusion

MK-677 does change the body: it raises IGF-1, adds some lean mass and body weight, and increases appetite. In controlled trials those changes were modest, came with higher blood sugar and swelling, and did not include fat loss or more strength. The dramatic reader results above show what people reported, often with SARMs, training and diet doing much of the work. If you have your own MK-677 before and after photos and want to share them, contact us.

Frequently asked questions

What are realistic MK-677 results?

ModestEvidence: Trial

In a 12-month trial in older adults, 25 mg/day added 1.1 kg of fat-free mass (vs a 0.5 kg loss on placebo) and 2.7 kg of body weight, with no change in strength or body fat. No trial has tested it in young people who lift.

Read the full section

How long does MK-677 take to show results?

IGF-1 in days; lean mass in monthsEvidence: Trial

IGF-1 is already higher after 7 days. Changes in fat-free mass were measured at 8 weeks in obese men and over 12 months in older adults.

Read the full section

What do MK-677 results look like after 8 weeks?

More lean mass, same fatEvidence: Trial

In the 8-week trial in obese men, fat-free mass rose while total and belly fat did not change. A big 8-week drop in body fat points to something other than MK-677.

Read the full section

Does MK-677 make you lose fat?

No, not in trialsEvidence: Trial

Total and belly fat did not change in older adults over 12 months or in obese men over 8 weeks, and limb fat rose more than on placebo in older adults.

Read the full section

Is the weight gain on MK-677 muscle or water?

Both, plus some fatEvidence: Trial

Fat-free mass, which includes water, rose in trials, mild swelling was common, and limb fat also rose. Body weight went up about 2 kg more than on placebo over a year.

Read the full section

What results do women get on MK-677?

Studied only in older womenEvidence: Trial

In 292 women aged 64 to 85 on 25 mg/day for up to 18 months, IGF-1 rose 39–45%, and weight gain and swelling were common side effects. No trial studied young women who train.

Read the full section

Sources

  1. FDA Briefing Document, Pharmacy Compounding Advisory Committee, 29 October 2024: Ibutamoren Mesylate 2024
  2. WADA: The Prohibited List (2026 List, in force from 1 January 2026) 2026
  3. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial 2008 · PMID 18981485
  4. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure 1998 · PMID 9467542
  5. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism 1998 · PMID 9467534
  6. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women 2001 · PMID 11238495
  7. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture 2004 · PMID 15066065
  8. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men 1996 · PMID 8768828
  9. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man 1997 · PMID 9349662
  10. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects 1996 · PMID 8954023
  11. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet 2017 · PMID 29183075
  12. Reversible Gynecomastia and Hypogonadism Due to Usage of Commercial Performance-Enhancing Supplement Use 2024 · PMID 39145153